5 Rivers Nutrition evidence guide to Shilajit for women, Ayurveda, postmenopausal bone research and safety

Shilajit Benefits for Women

In short: Shilajit is not established as a general women’s-health treatment. One relevant human study is a 48-week controlled trial in postmenopausal women with osteopenia; it does not prove that Shilajit balances hormones, treats menopause, improves fertility or works the same way in every woman.

Important: Shilajit Gold+ is a UK food supplement, not a medicine. If you are pregnant, breastfeeding, trying to conceive, using HRT or hormonal contraception, or taking prescription medication, speak to a pharmacist, GP or relevant specialist before use.

What has actually been studied in women?

Women are often given one of two poor answers about Shilajit. Either it is presented as a men's supplement, or research conducted in men is repackaged as proof of benefits for female hormones, fertility or energy. Neither approach is sound.

There is female-specific human evidence, but it needs to remain tied to the population, preparation and outcomes that were actually studied. The clearest example is a 48-week randomised, double-blind, placebo-controlled trial involving 60 postmenopausal women aged 45–65 with osteopenia. Researchers examined bone mineral density and related biomarkers. [1]

A separate small skeletal-muscle study examined changes in muscle gene expression after eight weeks of a particular purified Shilajit preparation in overweight or class I obese adults. [2] It did not establish that women taking Shilajit will feel more energetic or perform better.

Several prominent trials were conducted only in men. These include research on testosterone and an eight-week muscular-performance study. Findings from those studies should not be converted into claims about female hormones or everyday tiredness.

The 48-week postmenopausal bone trial

In the postmenopausal trial, participants with osteopenia received placebo, 250 mg per day or 500 mg per day of a standardised aqueous Shilajit extract for 48 weeks. Researchers measured bone mineral density at the lumbar spine and femoral neck, alongside bone-turnover, oxidative-stress and inflammatory markers. [1]

The decline in bone mineral density seen in the placebo group was attenuated in the Shilajit groups, with differences reported at weeks 24 and 48. This is a finding from one controlled trial in a defined population, not evidence of fracture prevention or treatment of osteoporosis.

What the study does not establish: It does not show that Shilajit raises or balances oestrogen, relieves menopausal symptoms, prevents fractures, reverses osteoporosis or produces the same result with every Shilajit preparation. It studied one standardised extract in postmenopausal women with osteopenia.

One controlled trial is a reason to take the subject seriously, not a reason to turn a specific result into a universal women's-health claim. Shilajit should not replace prescribed bone-health treatment, HRT where clinically indicated or appropriate monitoring.

Hormones, menopause, fertility, energy and hair

Hormonal balance. Good evidence does not currently establish that Shilajit generally “balances female hormones”. The frequently cited testosterone study involved healthy men aged 45–55. Male hormonal evidence is not female hormonal evidence.

Menopause. Research conducted in postmenopausal women is not automatically evidence for relief of hot flushes, night sweats, sleep disturbance or mood changes. The controlled trial measured bone-related outcomes, not menopause symptom relief.

Fertility. Human Shilajit research on reproductive outcomes has largely focused on men. It should not be used to claim improved ovulation, egg quality, conception or treatment of female infertility. If you are receiving fertility treatment, discuss the complete Gold+ formulation with your fertility team.

Energy and fatigue. Exercise-induced fatigue in a laboratory is not the same as everyday tiredness, work-related exhaustion or menopausal fatigue. A mixed-sex gene-expression study shows a biological response to one preparation, but it does not prove a female-specific improvement in subjective energy. Persistent or worsening fatigue deserves assessment rather than suppression.

Hair and skin. We do not currently rely on direct human evidence showing that Shilajit improves hair growth, density, shedding, wrinkles, elasticity or hydration in women. Proposed mechanisms and changes in laboratory markers are not substitutes for measured clinical outcomes.

Topic What the evidence currently supports
Postmenopausal bone health One controlled trial in postmenopausal women with osteopenia, using a specific standardised extract
Skeletal muscle Women were included in a small mixed-sex gene-expression study; this did not prove improved everyday energy
Hormones and menopause symptoms General hormonal balancing and menopause symptom relief have not been established
Female fertility Strong direct female-specific evidence is lacking
Hair and visible skin outcomes No verified evidence relied upon here for clinically meaningful cosmetic outcomes

The Ayurvedic perspective

In Ayurveda, Shilajit sits within the broader tradition of Rasayana, an approach concerned with sustaining vitality and resilience over time. Traditional use is not modern clinical proof, and Rasayana should not be retrofitted into claims about female hormones, fertility or disease treatment.

The traditional framework is broader than male performance. It considers the individual, including age, constitution, digestion, diet, strength and circumstance. That context can be relevant to women without turning Shilajit into a gendered cure-all.

“Rasayana, to me, is not about finding something powerful enough to override depletion. It is about building a life where you need to override yourself less often.”

That is the more useful founder perspective. Shilajit may sit within a wider routine, but it cannot replace sleep, food, movement, recovery or appropriate healthcare.

Safety and suitability for women

Pregnancy and breastfeeding. 5 Rivers Nutrition does not recommend Shilajit Gold+ during pregnancy or breastfeeding because adequate Shilajit-specific human safety evidence is unavailable. This is a precaution based on uncertainty, not proof of harm. If you used Gold+ before discovering you were pregnant, pause further use and discuss the complete product with your midwife, pharmacist or doctor.

Trying to conceive. Gold+ is not marketed as a preconception or female-fertility supplement. If you are undergoing fertility treatment, ask your fertility team to review the complete formulation before starting or continuing it.

HRT and hormonal contraception. A specific interaction has not been established in adequate human research. Lack of evidence is not evidence that every combination is safe. Ask a doctor or pharmacist to assess the complete formulation if you use HRT, the pill, an implant, injection, patch, hormonal coil or vaginal ring.

Heavy periods and persistent fatigue. Heavy menstrual bleeding can contribute to iron-deficiency anaemia, and tiredness may have many causes. Persistent, unexplained or worsening fatigue should not automatically be treated as a reason to take a supplement.

Medication and health conditions. If you take prescription medication or have an ongoing health condition, seek individual advice from a pharmacist, GP or relevant specialist. Do not stop or alter prescribed treatment because of information in this article.

Where Shilajit Gold+ fits

Shilajit Gold+ is not a separate “women's Shilajit”, and we do not give it hormone, fertility or beauty claims simply because the reader is female.

The studies discussed above used specific Shilajit preparations, not Shilajit Gold+. Their findings should not be transferred directly to our products. Gold+ Capsules and Resin also have different complete formulations, so suitability should be considered using the full ingredient list rather than generic information about Shilajit alone.

Our role is to provide clear formulation information, measured serving guidance and properly qualified information about the analytical reports for the submitted samples. Laboratory analysis can describe those samples; it does not prove that the product treats a condition, works for every woman or is safe for everyone.

If Shilajit fits your circumstances and earns a useful place in your wider routine, you can compare the two formats below. If it does not, that is a valid conclusion too.

View Shilajit Gold+ Capsules View Shilajit Gold+ Resin

Frequently asked questions

Is Shilajit specifically proven to work differently for women?

Human evidence is limited and depends on the preparation and outcome studied. A study in postmenopausal women with osteopenia examined bone mineral density and related measures over 48 weeks; it does not establish a general benefit for all women or for other outcomes.

Does Shilajit balance hormones or improve fertility?

The evidence reviewed here does not establish general hormone-balancing, menstrual, menopause-relief or female-fertility benefits. Speak with a qualified clinician about symptoms or fertility concerns.

Can Shilajit support bone health after menopause?

One randomised trial studied a standardised aqueous extract in postmenopausal women with osteopenia for 48 weeks. Its findings apply to that study group, product and measured outcomes; they do not show that any Shilajit product prevents or treats osteoporosis.

How long does Shilajit take to work for women?

No universal timeline is established. Study length describes the research protocol; it does not predict when an individual will notice an effect.

Is Shilajit safe during pregnancy or while taking medicine?

The evidence reviewed here is not enough to confirm safety for pregnancy, breastfeeding or a specific medicine combination. Check the complete product label with a clinician or pharmacist before use.

References

[1] Pingali U, Nutalapati C. Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial. Phytomedicine. 2022;105:154334. doi:10.1016/j.phymed.2022.154334

[2] Das A, et al. The human skeletal muscle transcriptome in response to oral Shilajit supplementation. Journal of Medicinal Food. 2016. doi:10.1089/jmf.2016.0010

[3] Pandit S, Biswas S, Jana U, De RK, Mukhopadhyay SC, Biswas TK. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. 2016;48(5):570–575. doi:10.1111/and.12482

Back to blog